Every record from Nordanalyt · page 3
The slowest and most precise contributor. The only lab here offering ion-pair, SEC and ICP-MS as routine. Measured offset against the reference laboratory is -0.005 pp on 357 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041291 | Semaglutide | WWB | WWB-2603-N3120 | 2026-Q2 | 99.33 | 6.56 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042963 | Retatrutide | KP | KP-2604-N4308 | 2026-Q2 | 98.57 | 5.08 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041287 | Semaglutide | WWB | WWB-2603-N3120 | 2026-Q2 | 99.04 | 6.47 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042861 | Retatrutide | GGPeps | GGPE-2601-C2423 | 2026-Q2 | 97.48 | 4.46 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041628 | BPC-157 | QSC | QSC-2511-N8732 | 2026-Q2 | 99.93 | 5.83 | 88.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042363 | Sermorelin | HJ | HJ-2605-A4196 | 2026-Q2 | 99.21 | 5.89 | 96.9 | Supplier-supplied | 0 | PASS |
| AX-2026-041840 | Tirzepatide | JEEP | JEEP-2602-J2798 | 2026-Q2 | 98.72 | 4.02 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042823 | TB-500 | GGPeps | GGPE-2605-J2051 | 2026-Q2 | 99.83 | 4.60 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041841 | Tirzepatide | JEEP | JEEP-2602-J2798 | 2026-Q2 | 99.44 | 4.45 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041670 | Semaglutide | QSC | QSC-2511-M9226 | 2026-Q2 | 98.95 | 3.39 | 101.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041501 | Kisspeptin-10 | QYB | QYB-2512-X5662 | 2026-Q2 | 99.93 | 3.58 | 107.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043140 | Tirzepatide | SSA | SSA-2511-N7115 | 2026-Q2 | 98.46 | 5.34 | 107.2 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042703 | Semaglutide | GGPeps | GGPE-2604-L9412 | 2026-Q2 | 99.25 | 4.81 | 100.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043340 | TB-500 | CPC | CPC-2605-B2433 | 2026-Q2 | 98.75 | 5.98 | — | Supplier-supplied | 4 | MARGINAL |
| AX-2026-042913 | Gonadorelin | MKM | MKM-2604-A2596 | 2026-Q2 | 99.89 | 5.07 | 98.0 | Supplier-supplied | 0 | PASS |
| AX-2026-041944 | Semax | TFC | TFC-2602-F4591 | 2026-Q2 | 99.93 | 9.37 | 91.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041809 | Tirzepatide | FGP | FGP-2605-R1831 | 2026-Q2 | 97.48 | 6.73 | 97.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041602 | Dihexa | QSC | QSC-2512-D7108 | 2026-Q2 | 99.93 | 5.89 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041599 | Dihexa | QSC | QSC-2512-D7108 | 2026-Q2 | 99.93 | 6.03 | 95.9 | Supplier-supplied | 0 | PASS |
| AX-2026-041600 | Dihexa | QSC | QSC-2512-D7108 | 2026-Q2 | 99.27 | 6.20 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042316 | Tirzepatide | HJ | HJ-2605-D3120 | 2026-Q2 | 98.22 | 4.63 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041446 | Liraglutide | QYB | QYB-2511-V5143 | 2026-Q2 | 98.86 | 5.10 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042351 | TB-500 | HJ | HJ-2511-L4170 | 2026-Q2 | 99.81 | 2.23 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042564 | Mazdutide | ERP | ERP-2603-D7882 | 2026-Q2 | 97.61 | 4.26 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042693 | Retatrutide | GGPeps | GGPE-2512-D9394 | 2026-Q2 | 98.76 | 4.16 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043008 | Tirzepatide | KP | KP-2602-X5446 | 2026-Q2 | 98.44 | 6.37 | 105.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043223 | SLU-PP-332 | SGN | SGN-2602-X9969 | 2026-Q2 | 98.29 | 5.81 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041746 | TB-500 | FGP | FGP-2512-Y9750 | 2026-Q2 | 99.93 | 3.76 | 88.8 | Supplier-supplied | 3 | FAIL |
| AX-2026-041438 | Oxytocin | QYB | QYB-2601-V5169 | 2026-Q2 | 99.93 | 3.89 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043157 | Ipamorelin | SSA | SSA-2604-G7599 | 2026-Q2 | 99.35 | 4.22 | 101.2 | Supplier-supplied | 3 | FAIL |
| AX-2026-042727 | Survodutide | GGPeps | GGPE-2512-Y9921 | 2026-Q2 | 97.45 | 3.38 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042122 | ARA-290 | Homopeptide | HOMO-2601-T8238 | 2026-Q2 | 99.57 | 3.74 | 90.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042760 | TB-500 | GGPeps | GGPE-2601-B9932 | 2026-Q2 | 99.05 | 4.21 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043280 | Hexarelin | CPC | CPC-2511-F1491 | 2026-Q2 | 98.16 | 5.29 | 96.0 | Buyer-sourced | 1 | FAIL |
| AX-2026-043249 | BPC-157 | SGN | SGN-2512-H1950 | 2026-Q2 | 99.07 | 4.67 | 95.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042865 | Retatrutide | GGPeps | GGPE-2601-C2423 | 2026-Q2 | 98.07 | 4.54 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042381 | Tirzepatide | SWB | SWB-2601-V4383 | 2026-Q1 | 99.23 | 3.53 | 94.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041669 | Semaglutide | QSC | QSC-2511-M9226 | 2026-Q2 | 99.22 | 4.06 | 94.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041420 | GHRP-2 | WWB | WWB-2511-K4194 | 2026-Q1 | 99.51 | 4.94 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041920 | PT-141 (Bremelanotide) | JEEP | JEEP-2603-G4602 | 2026-Q2 | 99.75 | 5.75 | 100.5 | Supplier-supplied | 0 | PASS |